Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002620662 | SCV003510425 | uncertain significance | not provided | 2023-01-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with KIAA0556-related conditions. This variant is present in population databases (rs762795797, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1617 of the KIAA0556 protein (p.Arg1617His). |
Baylor Genetics | RCV003147830 | SCV003835103 | uncertain significance | Joubert syndrome 26 | 2021-12-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004725554 | SCV005338568 | uncertain significance | KATNIP-related disorder | 2024-04-15 | no assertion criteria provided | clinical testing | The KATNIP c.4850G>A variant is predicted to result in the amino acid substitution p.Arg1617His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |